ResearcherAichi Medical UniversityActive in the last 2 years
Hayao Nakanishi
Matched on ORCID iD 0000-0002-8885-9404; OpenAlex author ID A5035622513. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- Sequential Changes in Circulating Tumor Cells in the Peripheral Blood of Pancreatic Cancer Patients with Preoperative Chemotherapy Using a New Immunocytology-B… Last author DOI 10.3390/diagnostics15060752↗
- Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer. Last author DOI 10.3390/cancers15225482↗
- Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation. Last author DOI 10.21873/anticanres.14701↗
- A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.4402↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tsuyoshi Sano · 1 shared paper, 2025 · strength 0.28
- Yasuyuki Fukami · 1 shared paper, 2025 · strength 0.28
- Kohei Yasui · 1 shared paper, 2025 · strength 0.28
- Yukako Ιtο · 2 shared papers, 2020–2023 · strength 0.28
- Paper Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft… DOI 10.3390/cancers15225482↗
- Paper Cytology-based Detection of Circulating Tumour Cells in Human Pancreatic Cancer Xenograft Models With KRAS Mutation. DOI 10.21873/anticanres.14701↗
- Yuzuru Ikehara · 2 shared papers, 2014–2020 · strength 0.17
- Mitsuro Kanda · 1 shared paper, 2023 · strength 0.17
- Yuki Matsui · 1 shared paper, 2020 · strength 0.11
- Takashi Yamaguchi · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.